XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 1,700 shares, a growth of 70.0% from the May 31st total of 1,000 shares. Based on an average daily trading volume, of 1,400 shares, the short-interest ratio is currently 1.2 days.
XOMA Price Performance
XOMA stock opened at $25.52 on Friday. XOMA has a fifty-two week low of $21.40 and a fifty-two week high of $25.98. The stock has a 50-day simple moving average of $25.19 and a 200-day simple moving average of $25.10.
XOMA Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Wednesday, July 3rd will be issued a $0.5391 dividend. This represents a $2.16 annualized dividend and a dividend yield of 8.45%. The ex-dividend date of this dividend is Wednesday, July 3rd.
XOMA Company Profile
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.
Featured Stories
- Five stocks we like better than XOMA
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Election Stocks: How Elections Affect the Stock Market
- MarketBeat Week in Review – 6/24 – 6/28
- Investing in Commodities: What Are They? How to Invest in Them
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.